文献速递关节外科

定义术前血红蛋白阈值有助于避免翻修全关节置换术的输血或不良事件

Defining Preoperative Hemoglobin Thresholds Can Help Avoid Transfusion or Adverse Events for Revision Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-10-27

该回顾性研究纳入2019至2024年连续翻修全膝关节置换术(rTKA)和翻修全髋关节置换术(rTHA)患者,评估术前血红蛋白阈值能否预测术中或术后输血及围手术期不良事件的降低可能性。结果显示术前血红蛋白对预测输血较预测不良事件更敏感和特异,且男性、无菌性病例所需阈值高于女性和感染性病例。作者认为这是首个在rTJA中定义术前血红蛋白阈值的研究,未来研究应进一步明确阈值。

要点

  • rTKA预测输血阈值:男性11.7 g/dL(AUC 0.868)vs女性11.5 g/dL(AUC 0.887)。
  • rTHA预测输血阈值:男性13.0 g/dL(AUC 0.776)vs女性12.0 g/dL(AUC 0.760)。
  • 预防输血所需血红蛋白阈值无菌性病例高于感染性病例(rTKA 11.9 vs 10.60 g/dL;rTHA 12.0 vs 10.9 g/dL)。

核心结论

  • 据作者所知,这是首个在翻修全关节置换术中定义术前血红蛋白阈值以尝试降低围手术期输血或不良事件可能性的研究。
  • 未来研究应进一步明确术前血红蛋白阈值以改进优化工作。

研究设计与样本

  • 回顾性审查2019年至2024年连续接受rTKA和rTHA的患者。
  • 排除标准为初次关节置换术、无术前血红蛋白值及1年随访不完整。
  • 使用术前血红蛋白值确定输血(术中及术后)和围手术期不良结局(定义为内科并发症、外科并发症、再入院或再翻修)的可能性。

主要发现

  • 术前血红蛋白在定义围手术期输血需求方面较围手术期不良事件更具敏感性和特异性。
  • 预测围手术期输血:rTKA男性阈值11.7 g/dL(AUC 0.868)vs女性11.5 g/dL(AUC 0.887);rTHA男性13.0 g/dL(AUC 0.776)vs女性12.0 g/dL(AUC 0.760)。
  • 预测围手术期不良事件:rTKA男性13.8 g/dL(AUC 0.693)vs女性12.50 g/dL(AUC 0.694);rTHA男性12.3 g/dL(AUC 0.571)vs女性11.9 g/dL(AUC 0.620)。
  • 预防输血所需血红蛋白阈值无菌性病例高于感染性病例:rTKA无菌性11.9 g/dL vs感染性10.60 g/dL;rTHA无菌性12.0 g/dL vs感染性10.9 g/dL。

关键数值与推荐

  • rTKA预测输血阈值:男性11.7 g/dL(AUC 0.868),女性11.5 g/dL(AUC 0.887)。
  • rTHA预测输血阈值:男性13.0 g/dL(AUC 0.776),女性12.0 g/dL(AUC 0.760)。
  • rTKA预测围手术期不良事件阈值:男性13.8 g/dL(AUC 0.693),女性12.50 g/dL(AUC 0.694)。
  • rTHA预测围手术期不良事件阈值:男性12.3 g/dL(AUC 0.571),女性11.9 g/dL(AUC 0.620)。
  • 预防输血阈值:rTKA无菌性11.9 g/dL vs感染性10.60 g/dL;rTHA无菌性12.0 g/dL vs感染性10.9 g/dL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anemia optimization before revision total joint arthroplasty (rTJA) could improve outcomes; however, there is little literature on hemoglobin optimization efforts before rTJA. Simulation models in orthopaedic literature help define the likelihood of successful surgery based on thresholds of preoperative parameters. We evaluated whether certain preoperative hemoglobin thresholds could be defined for revision total knee arthroplasty (rTKA) and revision total hip arthroplasty (rTHA) in order to predict reduced likelihood of intraoperative or postoperative transfusion or perioperative adverse events. METHODS: We retrospectively reviewed consecutive rTKA and rTHA patients from 2019 to 2024. Exclusion criteria were primary arthroplasty, no preoperative hemoglobin, and incomplete 1-year follow-up. Preoperative hemoglobin values were used to determine the likelihood of transfusion (intraoperative and postoperative) and perioperative adverse outcome (defined as medical complication, surgical complication, readmission, or re-revision). RESULTS: Preoperative hemoglobin was more sensitive and specific at defining the need for perioperative transfusion compared to perioperative adverse events. For both rTKA and rTHA, men required a higher preoperative hemoglobin threshold than women when predicting perioperative transfusion (rTKA: men 11.7 g/dL; area under the curve (AUC) 0.868 versus women 11.5 g/dL; AUC 0.887; rTHA: men 13.0 g/dL; AUC 0.776 versus women 12.0 g/dL; AUC 0.760) and perioperative adverse events (rTKA: men 13.8 g/dL AUC 0.693 versus women 12.50 g/dL; AUC 0.694; rTHA: men 12.3 g/dL AUC 0.571 versus women 11.9 g/dL; AUC 0.620). Higher hemoglobin thresholds were needed to prevent transfusion for aseptic cases (rTKA: 11.9 g/dL; rTHA: 12.0 g/dL) than septic cases (rTKA: 10.60 g/dL, rTHA: 10.9 g/dL). CONCLUSION: To our knowledge, this is the first study to define preoperative hemoglobin thresholds in rTJA in order to attempt to reduce the likelihood of perioperative transfusion or adverse events. Future studies should further delineate preoperative hemoglobin thresholds in order to improve optimization efforts.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sutton R, Sherman MB, Leipman JH, et al. Defining Preoperative Hemoglobin Thresholds Can Help Avoid Transfusion or Adverse Events for Revision Total Joint Arthroplasty. J Arthroplasty. 2025. PMID: 41161508. doi:10.1016/j.arth.2025.10.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。